Home › Niet-kleincellige longkanker › Colorado › Denver
Niet-kleincellige longkanker klinische studies in Denver, CO
27 studies voor Niet-kleincellige longkanker zoeken deelnemers op locaties in en rond Denver (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruterenFase 3
- Kaiser Permanente-Franklin, Denver
- National Jewish Health-Main Campus, Denver
- Rocky Mountain Cancer Centers - Swedish, Englewood · 6 mijl verwijderd
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruterenFase 1
- Sarah Cannon Research Institute at HealthOne, Denver
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- Rocky Mountain Cancer Center, Denver
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruterenFase 3
- Kaiser Permanente-Franklin, Denver
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RekruterenFase 3
- Rocky Mountain Cancer Centers,LLP, Denver
- Rocky Mountain Cancer Centers LLP, Denver
- Rocky Mountain Cancer Centers LLP, Englewood · 6 mijl verwijderd
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RekruterenFase 1/2
- Rocky Mountain Cancer Centers,LLP, Denver
Pan-tumor MRD Study
RekruterenObservatieonderzoek
- The Melanoma and Skin Cancer Institute, Englewood · 6 mijl verwijderd
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
RekruterenFase 3
- National Jewish Health Medical Center, Denver
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- SCRI at HCA HealthONE, Denver
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
RekruterenFase 3
- Clinical Study Site, Denver
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekruterenFase 2/3
- Local Institution - 007-872-E, Denver
- Local Institution - 007-872-I, Denver
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
RekruterenFase 1/2
- Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's, Denver
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- Sarah Cannon Research Institute at HealthOne, Denver
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
RekruterenFase 1
- Sarah Cannon Research Institute Denver, Denver
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
RekruterenFase 1
- Sarah Cannon Research Institute at HealthOne, Denver
SMP-3124LP in Adults With Advanced Solid Tumors
RekruterenFase 1/2
- Sarah Cannon Research Institute at HealthOne, Denver
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
RekruterenFase 1
- Sarah Cannon Research Institue At Healthone, Denver
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RekruterenFase 1
- Sarah Cannon Research Institute at HealthONE, Denver
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
RekruterenFase 1
- Sarah Cannon Research Institute at HealthONE, Denver
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RekruterenFase 1/2
- Sarah Cannon Research Institute, Denver
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- Sarah Cannon Research Institute (SCRI) at HealthONE, Denver
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruterenObservatieonderzoek
- Kaiser Permanente-Franklin, Denver
- Colorado Blood Cancer Institute, Denver
- Rocky Mountain Cancer Centers-Midtown, Denver
- en nog 1
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekruterenFase 1
- Dren Investigational Site, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Denver
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
RekruterenFase 1/2
- HealthONE Clinic Services Oncology - Hematology, LLC d/b/a Sarah Cannon Research Institute at HealthONE, Denver
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
RekruterenFase 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
Niet-kleincellige longkanker studies in andere steden
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Andere studies in Denver
- Metastatische kanker29 studies
- Borstkanker29 studies
- Multipel myeloom27 studies
- Colorectale kanker23 studies
- Melanoom19 studies
- Prostaatkanker19 studies
- Kanker (alle vormen)18 studies
- Eierstokkanker16 studies
- Longkanker16 studies
- Endometriumkanker15 studies
- Non-Hodgkinlymfoom14 studies
- Aldermeesklierkanker13 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.